Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

SPB Exchange reported for 2023 by RAS

3/29/24 SPBE

Europlan IPO was at the upper end of the price range

3/29/24 LEAS

Whoosh optimizes asset management structure in Latin America

3/29/24 WUSH

Element will launch production of power components

3/29/24 AFKS

HeadHunter CEO joins Cian's Board of Directors

3/28/24 CIAN

Shareholders of Cherkizovo Group approved dividends for 2023

3/28/24 GCHE

RusHydro will install electric charging stations on high-speed roads

3/28/24 HYDR

Astra reported for 2023 by RAS

3/28/24 ASTR

Magnit reported for 2023 by RAS

3/28/24 MGNT

Seligdar builds up Samolazovskoye's capacity

3/28/24 SELG